Reduced trans-mitral A-wave velocity predicts the presence of wild-type transthyretin amyloidosis in elderly patients with left ventricular hypertrophy
暂无分享,去创建一个
Y. Izumiya | K. Sakamoto | S. Hokimoto | D. Sueta | Satoshi Araki | K. Fujisue | S. Takashio | E. Yamamoto | K. Kaikita | K. Tsujita | H. Ogawa | M. Yamamuro | H. Yasuda | S. Kojima | K. Sugamura | H. Usuku | Shinsuke Hanatani | Yuichi Kimura | H. Kanazawa | Toshifumi Ishida | S. Yamamura | Y. Onoue | S. Araki | S. Hanatani | Hisanori Kanazawa
[1] N. Yamada,et al. Late gadolinium enhancement in cardiac amyloidosis: attributable both to interstitial amyloid deposition and subendocardial fibrosis caused by ischemia , 2016, Heart and Vessels.
[2] R. Falk,et al. Characterization of Cardiac Amyloidosis by Atrial Late Gadolinium Enhancement Using Contrast-Enhanced Cardiac Magnetic Resonance Imaging and Correlation With Left Atrial Conduit and Contractile Function. , 2015, The American journal of cardiology.
[3] P. Hari,et al. Clinical and imaging predictors of 1-year and long-term mortality in light chain (AL) amyloidosis: a 5-year follow-up study , 2014, Heart and Vessels.
[4] Y. Kanda,et al. Investigation of the freely available easy-to-use software ‘EZR' for medical statistics , 2012, Bone Marrow Transplantation.
[5] A. Boyd,et al. Echocardiographic evaluation of left atrial size and function: current understanding, pathophysiologic correlates, and prognostic implications. , 2008, American heart journal.
[6] A. Singleton,et al. Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2‐macroglobulin and tau: A population‐based autopsy study , 2008, Annals of medicine.
[7] S. Neubauer,et al. Evaluation and management of the cardiac amyloidosis. , 2007, Journal of the American College of Cardiology.
[8] Cheuk-Man Yu,et al. Tissue Doppler imaging a new prognosticator for cardiovascular diseases. , 2007, Journal of the American College of Cardiology.
[9] R. Falk. Diagnosis and Management of the Cardiac Amyloidoses , 2005, Circulation.
[10] J. Seward,et al. Left atrial myopathy in cardiac amyloidosis: implications of novel echocardiographic techniques. , 2005, European heart journal.
[11] P. Nihoyannopoulos,et al. Left atrial systolic function in primary and familial amyloidosis: Assessment from left atrial volume change , 2004, Clinical cardiology.
[12] Richard E Thompson,et al. Noninvasive diagnosis of biopsy-proven cardiac amyloidosis. , 2004, Journal of the American College of Cardiology.
[13] R. Falk,et al. Left atrial kinetic energy in AL amyloidosis: can it detect early dysfunction? , 2000, The American journal of cardiology.
[14] R. Falk,et al. Atrial thrombi occurring during sinus rhythm in cardiac amyloidosis: evidence for atrial electromechanical dissociation. , 1995, British heart journal.
[15] W. Manning,et al. Temporal dependence of the return of atrial mechanical function on the mode of cardioversion of atrial fibrillation to sinus rhythm. , 1995, The American journal of cardiology.
[16] J. Seward,et al. Effects of age on left ventricular dimensions and filling dynamics in 117 normal persons. , 1994, Mayo Clinic proceedings.
[17] J. Plehn,et al. Atrial systolic failure in primary amyloidosis , 1992 .
[18] J. Seward,et al. Prognostic Significance of Doppler Measures of Diastolic Function in Cardiac Amyloidosis: A Doppler Echocardiography Study , 1991, Circulation.
[19] J. Seward,et al. Serial Doppler echocardiographic follow-up of left ventricular diastolic function in cardiac amyloidosis. , 1990, Journal of the American College of Cardiology.